HqMOLYTIC-URqMIC SYNDROME: DEFICIENCY OF PLASMA FACTOR(S) REGULATING PROSTACYCLIN ACTIVITY?
- 1 October 1978
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 312 (8095) , 871-872
- https://doi.org/10.1016/s0140-6736(78)91573-8
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- TREATMENT OF IDIOPATHIC ORTHOSTATIC HYPOTENSION (SHY-DRAGER SYNDROME) WITH INDOMETHACINThe Lancet, 1978
- Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial IschemiaScience, 1978
- PROSTACYCLIN-LIKE ACTIVITY AND BLEEDING IN RENAL FAILUREThe Lancet, 1977
- PLASMAPHERESIS IN TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA1977
- Antiplatelet Treatment of Thrombotic Thrombocytopenic PurpuraAnnals of Internal Medicine, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Scleroderma and Microangiopathic Hemolytic AnemiaAnnals of Internal Medicine, 1973